TANDEM(R)-R CARCINOEMBRYONIC ANTIGEN ASSAY

System, Test, Carcinoembryonic Antigen

FDA Premarket Approval P840019 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceTANDEM(R)-R CARCINOEMBRYONIC ANTIGEN ASSAY
Classification NameSystem, Test, Carcinoembryonic Antigen
Generic NameSystem, Test, Carcinoembryonic Antigen
ApplicantHYBRITECH, INC.
Date Received1984-08-01
Decision Date1985-03-25
PMAP840019
SupplementS001
Product CodeDHX
Advisory CommitteeImmunology
Expedited ReviewNo
Combination Product No
Applicant Address HYBRITECH, INC. 11095 Torreyana Rd. p.o. Box 269006 san Diego, CA 92126

Supplemental Filings

Supplement NumberDateSupplement Type
P840019Original Filing
S012 1995-09-21 Normal 180 Day Track
S011 1992-11-25 Normal 180 Day Track
S010 1991-09-05 Normal 180 Day Track
S009 1990-03-14 Normal 180 Day Track
S008 1989-11-09 Normal 180 Day Track
S007 1989-08-18 Normal 180 Day Track
S006 1987-02-09 Normal 180 Day Track
S005 1986-09-17 Normal 180 Day Track
S004 1986-03-20 Normal 180 Day Track
S003 1985-08-23
S002 1985-03-29
S001 1984-08-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.